As the need arises for specialty molecules to treat chronic diseases, and as new technologies become available to produce natural, synthetic and bio-synthetic APIs with better results, Noramco will adopt special purpose technology platforms.
These include, but are not limited to platforms pertaining to:
- Custom synthesis products
- APIs produced by bio-catalysis
- Controlled substance building blocks and intermediates